Breast lesions: Imaging with contrast-enhanced subharmonic US - Initial experience

Radiology

Volumn 244, Issue 3, 2007, Pages 718-726

  Forsberg, Flemming ^a   Piccoli, Catherine W ^a,c   Merton, Daniel A ^a   Palazzo, Juan J ^a   Hall, Anne L ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b GE HEALTHCARE   (United States)

^c South Jersey Orthopedic Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DOPPLER ECHOGRAPHY; FEMALE; FOLLOW UP; GRAY SCALE ECHOGRAPHY; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; MAMMOGRAPHY; PILOT STUDY; PRIORITY JOURNAL; ROC CURVE; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; ALBUMINS; BREAST NEOPLASMS; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUOROCARBONS; HUMANS; MAMMOGRAPHY; MIDDLE AGED; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, DOPPLER; ULTRASONOGRAPHY, MAMMARY;

EID: 34548076146     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2443061588     Document Type: Article

References (46)

1. Tabár L, Dean PB. Mammography and breast cancer: the new era. Int J Gynaecol Obstet 2003;82:319-326.
2. Kopaus DB. Breast imaging. 2nd ed. Philadelphia, Pa: Lippincott Williams & Wilkins, 1998.
3. Zonderland HM, Coerkamp EG, Hermans J, van de Vijver MJ, van Voorthuisen AE. Diagnosis of breast cancer: contribution of US as an adjunct to mammography. Radiology 1999;213:413-422.
4. Stavros AT, Thickman D, Rapp CL, Dennis MA, Parker SH, Sisney GA. Solid breast nodules: use of sonography to distinguish between benign and malignant lesions. Radiology 1995;196:123-134.
5. Taylor KJ, Merritt C, Piccoli C, et al. Ultrasound as a complement to mammography and breast examination to characterize breast masses. Ultrasound Med Biol 2002;28:19-26.
6. Bohm-Velez M, Mendelson EB. Computed tomography, duplex Doppler ultrasound and magnetic resonance imaging in evaluating the breast. Semin Ultrasound CT MR 1989;10:171-176.
7. Adler DD, Carson PL, Rubin JM, Quinn-Reid D. Doppler ultrasound color flow imaging in the study of breast cancer: preliminary findings. Ultrasound Med Biol 1990;16:553-559.
8. Ferrara KW, Merritt CR, Burns PN, Foster FS, Mattrey RF, Wickline SA. Evaluation of tumor angiogenesis with US: imaging, Doppler and contrast agents. Acad Radiol 2000;7:824-839.
9. Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast cancer. J Natl Cancer Inst 1992;84:1875-1887.
10. Gasparini G, Harris AL. Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. J Clin Oncol 1995;13:765-782.
11. Relf M, LeJeune S, Scott PA, et al. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res 1997;57:963-969.
12. Goldberg BB, Raichlen JS, Forsberg F. Ultrasound contrast agents: basic principles and clinical applications. 2nd ed. London, England: Dunitz, 2001.
13. Albrecht T, Hoffman CW, Schettler S, et al. B-mode enhancement using phase-inversion US with air-based microbubble contrast agent: initial experience in humans. Radiology 2000;216:273-278.
14. Forsberg F, Liu JB, Chiou HJ, Rawool NM, Parker L, Goldberg BB. Comparison of fundamental and wideband harmonic contrast imaging of liver tumors. Ultrasonics 2000;38:110-113.
15. Wilson SR, Burns PN, Muradali D, Wilson JA, Lai X. Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma and metastasis. Radiology 2000;215:153-161.
16. Kim TK, Choi BI, Han JK, Park SH, Moon SG. Hepatic tumors: contrast agent-enhancement patterns with pulse-inversion harmonic US. Radiology 2000;216:411-417.
17. Forsberg F, Shi WT, Goldberg BB. Subharmonic imaging of contrast agents. Ultrasonics 2000;38:93-98.
18. Shi WT, Forsberg F, Hall AL, et al. Subharmonic imaging with microbubble contrast agents: initial results. Ultrason Imaging 1999;21:79-94.
19. Shi WT, Forsberg F, Raichlen JS, Needleman L, Goldberg BB. Pressure dependence of subharmonic signals from contrast microbubbles. Ultrasound Med Biol 1999;25:275-283.
20. Bhagavatheeshwaran G, Shi WT, Forsberg F, Shankar PM. Subharmonic generation from contrast agents in simulated neovessels. Ultrasound Med Biol 2004;30:199-203.
21. Forsberg F, Liu JB, Shi WT, Furuse J, Shimizu M, Goldberg BB. In vivo pressure estimation using subharmonic contrast microbubble signals: proof of concept. IEEE Trans Ultrason Ferroelectr Freq Control 2005;52:581-583.
22. Forsberg F, Liu JB, Shi WT, et al. In vivo perfusion estimation using subharmonic contrast microbubble signals. J Ultrasound Med 2006;25:15-21.
23. Shankar PM, Krishna PD, Newhouse VL. Advantage of subharmonic over second harmonic backscatter for contrast-to-tissue echo enhancement. Ultrasound Med Biol 1998;24:395-399.
24. Chomas J, Dayton P, May D, Ferrara K. Nondestructive subharmonic imaging. IEEE Trans Ultrason Ferroelectr Freq Control 2002;49:883-892.
25. Goertz DE, Cherin E, Needles A, et al. High frequency nonlinear B-scan imaging of microbubble contrast agents. IEEE Trans Ultrason Ferroelectr Freq Control 2005;52:65-79.
26. Goertz DE, Needles A, Burns PN, Foster FS. High-frequency, nonlinear flow imaging of microbubble contrast agents. IEEE Trans Ultrason Ferroelectr Freq Control 2005;52:495-502.
27. Ganor Y, Adam D, Kimmel E. Time and pressure dependence of acoustic signals radiated from microbubbles. Ultrasound Med Biol 2005;31:1367-1374.
28. Drug Alert Class I Medicines Recall-Amersham Health AS (Part of GE Healthcare)-Optison Suspension for Injection 3ml Vial. Medicines and Healthcare Products Regulatory Agency. November 23rd, 2005. http://www.info.doh.gov.uk/doh/ EmBroadcast.nsf/0/641a8cc5d80ba800802570c2003f54fd?OpenDocument. Accessed March 29, 2006.
29. Forsberg F, Liu JB, Burns PN, Merton DA, Goldberg BB. Artifacts in ultrasonic contrast agent studies. J Ultrasound Med 1994;13:357-365.
30. American College of Radiology. Breast imaging reporting and data system. 3rd ed. Reston, Va: American College of Radiology, 1998.
31. Forsberg F, Goldberg BB, Merritt CR, et al. Diagnosing breast lesions with contrast-enhanced 3-dimensional power Doppler imaging. J Ultrasound Med 2004;23:173-182.
32. Metz CE. ROC methodology in radiologic imaging. Invest Radiol 1986;21:720-733.
33. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837-845.
34. Rosner B. Fundamentals of biostatistics. 3rd ed. Boston, Mass: PWS-Kent, 1990.
35. Kedar RP, Cosgrove D, McCready VR, Bamber JC, Carter ER. Microbubbble contrast agent for color Doppler US: effect on breast masses. Radiology 1996;198:679-686.
36. Madjar H, Prompeler HJ, Del Favero C, Hackeloer BJ, Llull JB. A new Doppler signal enhancing agent for flow assessment in breast lesions. Eur J Ultrasound 2000;12:123-130.
37. Stuhrmann M, Aronius R, Schietzel M. Tumor vascularity of breast lesions: potentials and limits of contrast-enhanced Doppler sonography. AJR Am J Roentgenol 2000;175:1585-1589.
38. Goldberg BB, Merritt CRB, Needleman L, et al. Contrast enhanced ultrasound and mammography for breast cancer detection [abstr]. J Ultrasound Med 2001;20:S95.
39. Furuse F, Forsberg F, Goldberg BB, et al. Pulse inversion harmonic imaging for breast cancer diagnosis [abstr]. Ultrasound Med Biol 2003;29:S93-S94.
40. Kim SW, Park SS, Ahn SJ, et al. Identification of angiogenesis in primary breast carcinoma according to the image analysis. Breast Cancer Res Treat 2002;74:121-129.
41. Yang WT, Tse GM, Lam PK, Metreweli C, Chang J. Correlation between color power Doppler sonographic measurement of tumor vasculature and immunohistochemical analysis of microvessel density for the quantitation of angiogenesis. J Ultrasound Med 2002;21:1227-1235.
42. Hochmuth A, Boehm T, Bitzer C, Fleck M, Schneider A, Kaiser WA. Differentiation of breast masses using 3-D sonographic and echo-enhancer-based evaluation of the vascular pattern: initial experiences. Ultrasound Med Biol 2002;28:845-851.
43. Zdemir A, Kilic K, Ozdemir H, Yucel C, Andac S, Colak M. Contrast-enhanced power Dopplec sonography in breast lesions: effect on differential diagnosis after mammography and gray scale sonography. J Ultrasound Med 2004;23:183-195.
44. Kettenbach J, Helbich TH, Huber S, Zuna I, Dock W. Computer-assisted quantitative assessment of power Doppler US: effects of microbubble contrast agent in the differentiation of breast tumors. Eur J Radiol 2005;53:238-244.
45. Cassano E, Rizzo S, Bozzini A, Menna S, Bellomi M. Contrast enhanced ultrasound of breast cancer. Cancer Imaging 2006;6:4-6.
46. Jung EM, Jungius KP, Rupp N, et al. Contrast enhanced harmonic ultrasound for differentiating breast tumors: first results. Clin Hemorheol Microcirc 2005;33:109-120.